http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0971728-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5181f7bc41146d952cf4e72f866a39ca |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-14 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2086 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
filingDate | 1998-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aeb6d7634a866d2b1738e3be665821f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bbb4c538b9158654a5b3a5c20071aa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7da7fa42e4743b260ab333d48a0ea54 |
publicationDate | 2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0971728-B1 |
titleOfInvention | Use of interleukin-15 |
abstract | The invention relates to the use of IL-15 inhibiting or eliminating compounds that interfere with the binding of IL-15 to its receptor for the manufacture of a pharmaceutical composition for suppression of formation of CD4<+> memory cells of the immune system. Such inhibiting or eliminating compounds are for example anti-IL-15 antibodies, anti-IL-15R alpha antibodies, fragments of these antibodies, e.g. the Fab or F(ab')2 fragment, soluble IL-15R alpha , fusion proteins consisting of soluble IL-15R alpha , and Fc fragment, compounds, e.g. peptides, binding and/or inhibiting functional IL-15 receptor, IL-15 antisense oligonucleotides. |
priorityDate | 1997-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.